IPV-Boostrix– Suspension for injection in a pre-filled syringeDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) Ireland - English - HPRA (Health Products Regulatory Authority)

ipv-boostrix– suspension for injection in a pre-filled syringediphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

glaxosmithkline (ireland) limited - diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin (fha); pertactin; type 1 (mahoney); type 2 (mef-1); type 3 (saukett) - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - diphtheria-pertussis-poliomyelitis-tetanus

Adacel, suspension for injection.Diphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content) Malta - English - Medicines Authority

adacel, suspension for injection.diphtheria, tetanus, pertussis (acellular component) vaccine (adsorbed, reduced antigen(s) content)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - pertactin, pertussis toxoid, diphtheria toxoid, filamentous haemagglutinin, fha, fimbriae types, and, tetanus toxoid - suspension for injection - pertactin 3 µg pertussis toxoid 2.5 µg diphtheria toxoid filamentous haemagglutinin (fha) 5 µg fimbriae types 2 and 3 5 µg tetanus toxoid - vaccines

Boostrix – Suspension for injection. Diphtheria, tetanus and acellular pertussis (adsorbed) vaccine Malta - English - Medicines Authority

boostrix – suspension for injection. diphtheria, tetanus and acellular pertussis (adsorbed) vaccine

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis toxoid, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection - pertactin 2.5 µg pertussis toxoid 8 µg diphtheria toxoid filamentous haemagglutinin (fha) 8 µg tetanus toxoid - vaccines

IPV Infanrix, suspension for injection in pre-filled syringe. Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed) Malta - English - Medicines Authority

ipv infanrix, suspension for injection in pre-filled syringe. diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, tetanus toxoid - suspension for injection in pre-filled syringe - pertactin 8 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu diphtheria toxoid filamentous haemagglutinin (fha) 25 µg tetanus toxoid - vaccines

PEDIACEL, suspension for injection in pre-filled syringe.Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed) Malta - English - Medicines Authority

pediacel, suspension for injection in pre-filled syringe.diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - pertactin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, filamentous haemagglutinin, fha, fimbriae types, and, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - suspension for injection in pre-filled syringe - pertactin 3 µg pertussis toxoid 20 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu diphtheria toxoid filamentous haemagglutinin (fha) 20 µg fimbriae types 2 and 3 5 µg haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines

INFANRIX-IPV+Hib powder and suspension for suspension for injection. Diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed) Malta - English - Medicines Authority

infanrix-ipv+hib powder and suspension for suspension for injection. diphtheria, tetanus, pertussis (acellular component), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - pertactin, pertussis filamentous, haemagglutinin, pertussis toxoid, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, diphtheria toxoid, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate, tetanus toxoid - powder and suspension for suspension for injection - pertactin 8 µg pertussis filamentous haemagglutinin 25 µg pertussis toxoid 25 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu/0.5ml poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu/0.5ml poliovirus (inactivated) type 3 (saukett strain) 32 dagu/0.5ml diphtheria toxoid haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg tetanus toxoid - vaccines

Pentavac Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and Haemophilus influenzae type b co Ireland - English - HPRA (Health Products Regulatory Authority)

pentavac diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) and haemophilus influenzae type b co

sanofi pasteur - purified diphtheria toxoid ph. eur.; purified tetanus toxoid; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus; haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0.5 millilitre(s) - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

TdaPBooster, suspension for injection in pre-filled syringe.Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content) Ireland - English - HPRA (Health Products Regulatory Authority)

tdapbooster, suspension for injection in pre-filled syringe.diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

aj vaccines a/s - diphtheria toxoid, purified; tetanus toxoid, purified; pertussis toxoid, purified - suspension for injection in pre-filled syringe - < 2 international unit(s) - pertussis vaccines; pertussis, purified antigen, combinations with toxoids

Pediacel New Zealand - English - Medsafe (Medicines Safety Authority)

pediacel

sanofi-aventis new zealand limited - diphtheria toxoid, adsorbed 15 lf u; haemophilus influenzae type b polysaccharide 10ug; pertactin 3ug (adsorbed); pertussis filamentous haemagglutinin 20ug (adsorbed); pertussis fimbriae 2+3 5ug (adsorbed); pertussis toxoid, adsorbed 20ug; polio virus type 1 40 dagu (mahoney, inactivated); polio virus type 2 8 dagu (m e f 1, inactivated); polio virus type 3 32 dagu (saukett, inactivated); tetanus toxoid 20ug (covalently bound to hib prp); tetanus toxoid, adsorbed 5 lf u - suspension for injection - active: diphtheria toxoid, adsorbed 15 lf u haemophilus influenzae type b polysaccharide 10ug pertactin 3ug (adsorbed) pertussis filamentous haemagglutinin 20ug (adsorbed) pertussis fimbriae 2+3 5ug (adsorbed) pertussis toxoid, adsorbed 20ug polio virus type 1 40 dagu (mahoney, inactivated) polio virus type 2 8 dagu (m e f 1, inactivated) polio virus type 3 32 dagu (saukett, inactivated) tetanus toxoid 20ug (covalently bound to hib prp) tetanus toxoid, adsorbed 5 lf u excipient: aluminium phosphate bovine serum albumin formaldehyde glutaral neomycin phenoxyethanol polymyxin b sulfate polysorbate 80 streptomycin water for injection - pediacel is indicated for the primary immunisation of children from 6 weeks of age against diphtheria, tetanus, pertussis, poliomyelitis and invasive haemophilus influenzae type b disease. pediacel® is also indicated for the fourth dose for children from 15 months of age up to 20 months who have been immunised previously with up to three doses of diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b disease vaccines.

Poliacel New Zealand - English - Medsafe (Medicines Safety Authority)

poliacel

sanofi-aventis new zealand limited - diphtheria toxoid, adsorbed 15 lf u; pertactin 3ug (adsorbed); pertussis filamentous haemagglutinin 20ug (adsorbed); pertussis fimbriae 2+3 5ug (adsorbed); pertussis toxoid, adsorbed 20ug; polio virus type 1 40 dagu (inactivated); polio virus type 2 8 dagu (inactivated); polio virus type 3 32 dagu (inactivated); tetanus toxoid, adsorbed 5 lf u; haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein (18-30µg)) - combination - active: diphtheria toxoid, adsorbed 15 lf u pertactin 3ug (adsorbed) pertussis filamentous haemagglutinin 20ug (adsorbed) pertussis fimbriae 2+3 5ug (adsorbed) pertussis toxoid, adsorbed 20ug polio virus type 1 40 dagu (inactivated) polio virus type 2 8 dagu (inactivated) polio virus type 3 32 dagu (inactivated) tetanus toxoid, adsorbed 5 lf u excipient: aluminium phosphate bovine serum albumin formaldehyde glutaral neomycin phenoxyethanol polymyxin b polysorbate 80 water for injection active: haemophilus influenzae type b polysaccharide 10ug (conjugated to tetanus protein (18-30µg)) excipient: sucrose trometamol - poliacel® is indicated for primary immunisation of children from the age of 2 months to 12 months against diphtheria, tetanus, whooping cough, poliomyelitis and invasive haemophilus influenzae type b disease. poliacel® is also indicated for the fourth dose for children from 15 to 20 months who have been immunised previously with up to three doses of diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b disease vaccines.